Skip to main content
Premium Trial:

Request an Annual Quote

One Lambda HLA Software Cleared by US, Canadian Regulators

NEW YORK (GenomeWeb News) – Regulators in the US and Canada have cleared One Lambda's companion software to molecular typing and antibody screening products, the Thermo Fisher Scientific business said late Wednesday.

The US Food and Drug Administration cleared the HLA Fusion Software version 3.0, while Canada's Ministry of Health has also granted the software a Health Canada License.

One Lamba's software is used to help personnel experienced in HLA analysis by suggesting typing and antibody screening results, the company said, adding that HLA Fusion Software version 3.0 is intended as a laboratory aid, not for definitive results.

Thermo Fisher acquired One Lambda, which specializes in transplant diagnostics, in September for $925 million.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.